| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |